Waist–hip ratio and breast cancer risk in urbanized Nigerian women by Adebamowo, Clement A et al.
18
Introduction
Breast cancer is the leading female malignancy in the
world and is now the most common cancer in Nigeria
[1–3]. Despite this, there is a sixfold variation in incidence
when Western countries are compared with the develop-
ing countries of Africa and Asia, and immigrants from low
incidence countries tend to acquire the rate of their new
environments [2,4]. Some of this variation may be due to
demographic factors such as longer life expectancy,
better reporting of disease and improved access to clini-
cal care. There is increasing interest, however, in the rela-
tive importance of environmental and genetic factors as
explanations for this difference.
In general, African breast cancer patients tend to present at
a young age, with large tumors and multiple nodal involve-
ments, and have poorer clinical and pathological prognostic
factors compared with Caucasian patients. These charac-
teristics are somewhat similar to that of African-Americans
but are in contrast with those of non-Hispanic Whites in the
USA, thus heightening the interest in the role of genetic
factors in the etiology of breast cancer in general, and in
people of African origin in particular [3,5].
One of the often cited reasons for the difference in breast
cancer incidence in Africa compared with Western coun-
tries is the difference in environmental risk factors such as
BMI = body mass index; LRT = likelihood ratio test; SHBG = sex hormone binding globulin; WHR = waist–hip ratio.
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Abstract
Background: The aim of the study was to examine the
relationship between waist–hip ratio and the risk of breast
cancer in an urban Nigerian population.
Methods: Between March 1998 and August 2000, we
conducted a case–control study of hospital-based breast
cancer patients (n=234) and population-based controls
(n=273) using nurse interviewers in urban Southwestern
Nigeria.
Results: Multivariable logistic regression showed a significant
association between the highest tertile of waist–hip ratio and
the risk of breast cancer (odds ratio=2.67, 95% confidence
interval=1.05–6.80) among postmenopausal women. No
association was found in premenopausal women.
Conclusion: The present study, the first in an indigenous
African population, supports other studies that have shown a
positive association between obesity and breast cancer risk
among postmenopausal women.
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diet and physical activity (both contributing to obesity),
use of hormones/other medications, and obstetric/gyne-
cological practices [6]. In the current paper, we present
the results of the first study of the association between
waist–hip ratio (WHR) and breast cancer in an indigenous
African population.
The WHR has emerged as an important metameter of the
association between central adiposity and many obesity-
related diseases. Positive correlations have been seen with
coronary heart disease, adult-onset diabetes mellitus and
stroke [7]. However, the result with breast cancer has been
inconsistent [8]. Abdominal obesity may be related to
breast cancer through aberrant insulin signaling leading to
increased endogenous androgen and estrogen levels [9].
Methods
Case ascertainment
All consecutive cases of breast cancer, regardless of pre-
vious history, seen at presentation and later confirmed his-
tologically in the Departments of Surgery and
Radiotherapy of the University College Hospital, Ibadan,
Nigeria, from March 1998 to August 2000 were recruited
at their first clinic presentation, after obtaining informed
consent. Nurse interviewers asked them which risk factors
did apply at the time when they were last well. The inter-
viewer then measured the height, weight, and hip circum-
ference at its widest diameter. Waist circumference was
measured according to the guidelines in the World Health
Organization MONICA Project manual [10].
There were 312 cases, of which 73 indicated that they
had lived predominantly in a rural area and were excluded.
There were five refusals and no further information was
available from these, leaving 234 cases.
Control ascertainment
During the period of case recruitment, a community adjoin-
ing the hospital was randomly selected by ballot based on
comparability with the hypothetical catchment area of the
hospital. Community consent was sought from the Chief-
in-Council and approval for the study was communicated
to members of the community through heads of house-
holds. The census register of the people living in the com-
munity was obtained and community consent sought for
the study. Names were then randomly selected from the
community register and the people were invited to visit a
clinic set up in the community for the study.
Inclusion criteria for the controls were females aged older
than 18 years, absence of any type of cancer at recruit-
ment, predominant urban residence for most of their lives
and the ability to give informed consent. No matching of
controls to cases was performed. After explaining the
project to the potential participant, a complete physical
examination was carried out. A trained nurse then inter-
viewed the participants, measured their height, their
weight, their hip circumference at its widest diameter and
their waist circumference 1 inch below the navel, and
completed the questionnaires. A total of 278 subjects
were interviewed, of which 273 were recruited; there were
three refusals, and two people were not recruited on
account of a diagnosis of cancer (head of the pancreas
cancer in one and colorectal cancer in the other).
Data collection and analysis
The information obtained from the cases and controls
include age, self-reported social status based on family
income and other baseline demographic information.
Obstetric and gynecological history such as age of onset
of menarche, menstrual cycle history, whether periods had
usually been regular, age at onset of menopause (natural
or otherwise) and history of previous breast disease, as
well as smoking, drug and alcohol use history, were
obtained from the subjects. Other information obtained
included first-degree family history of breast cancer,
history of ever using estrogen-containing contraceptives
and where they had lived most of their lives (whether in a
rural or urban setting). No information about post-
menopausal hormonal use was obtained as this is an
uncommon practice in Nigeria.
The body mass index (BMI) (weight [kg]/height [m2];
obesity = BMI≥30) and WHR were computed (waist cir-
cumference [cm]/hip circumference [cm]), and four sub-
jects with WHR>1.2 and WHR<0.6 were excluded. The
rest were divided into tertiles and treated as categories.
Statistical analysis of the data was carried out with SAS
version 8.0 (SAS Institute, Inc., Cary, NC, USA) separately
for premenopausal and postmenopausal women. Univari-
ate analysis was used to identify variables to be included
in multivariable analysis using P≤0.10. Purposeful step-
wise multivariable logistic regression models were built to
identify statistically significant variables at P=0.05, and a
10% or greater change in the β-coefficient was used to
identify confounders. In addition, automated stepwise mul-
tivariate logistic regression models were run as an adjunct
to the aforementioned method.
Continuous variables were examined for assumption of lin-
earity; age and age at onset of regular menstrual periods
were found to be nonlinear. Age was subsequently divided
into 5-year categories while age at onset of regular men-
strual periods was left as it was because the range of
values was narrow, but it was subsequently modeled as a
categorical variable.
Results
The WHR in this study was measured at presentation in
cases and, since most patients presented in an advanced
stage of disease, there may have been significant weight
loss among the cases prior to recruitment. However, thereBreast Cancer Research    Vol 5 No 2 Adebamowo et al.
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was no significant difference in the frequency of the stage
of disease (based on size of tumor at presentation) by
obesity (BMI>30) among premenopausal (P [chi-squared
test]=0.18) and postmenopausal women (P=0.20) on
the one hand, and in WHR among premenopausal women
(P=0.26) and postmenopausal women (P=0.63) on the
other.
Premenopausal women
Tables 1 and 2 present the results of age-adjusted analy-
sis. Increasing age and age at first full-term pregnancy
were positively associated with risk of breast cancer, while
increasing age at onset of menarche was protective.
Overall, categories of WHR were not significantly associ-
ated with the risk of breast cancer but there was a margin-
ally significant test of trend for a positive association
between increasing WHR and breast cancer risk. There
was no association with total number of pregnancies,
height, obesity (BMI≥30) weight, BMI, waist and hip cir-
cumferences, family history of breast cancer, having ever
breastfed and use of oral contraceptives. In multivariable
logistic regression analysis, adjusted for age, age at
menarche, age at first pregnancy and height, there was no
significant association between the WHR and breast
cancer risk (Table 3).
Postmenopausal women
On the other hand, in age-adjusted logistic regression
models among postmenopausal women (Tables 4 and 5),
increasing age was associated with a reduced breast
cancer risk, while increasing height, waist circumference
and obesity (BMI≥30) were positively associated with
breast cancer risk. There was a significant association
with the highest tertile of WHR but the likelihood ratio test
(LRT) for trend (P = 0.07) was not significant. The associ-
ation with having ever breastfed could not be ascertained
because of an inadequate sample size. In multivariable
logistic regression analysis, adjusted for age and height,
there was a significant association between the highest
tertile of WHR and breast cancer risk (LRT P = 0.10;
Table 6).
Discussion
The earliest reports of the positive association between
energy balance and breast cancer date back to 1942
[11]. Numerous case–control and cohort studies have
subsequently supported this association. However, the
strength of the association and the category of patients in
whom the association was seen varied from study to
study. In addition, there are methodological concerns
about the most appropriate measure of obesity, and which
component or type of obesity is etiologically significant.
The WHR, a measure of central adiposity, is gaining
increased use as a measure of etiologically significant
obesity and is thought to be more closely related to
pathology, especially coronary heart disease, diabetes
mellitus and stroke [7]. The metabolic changes that
accompany obesity include peripheral hyperinsulinemia,
hyperglycemia and glucose intolerance, hypertrigly-
ceridemia, decreased serum low-density lipoprotein,
increased serum very low-density lipoprotein, increased
serum leptin, dyslipidemia, increased serum cortisol clear-
ance, increased serum C-peptide level, downregulation of
insulin receptors and an exaggerated insulin response to
an oral glucose load [12–15]. These changes, especially
when they occur in early adulthood, may be of fundamen-
tal importance in the development of breast cancer [9,16].
Obesity is also associated with significant hormonal
changes such as decreased serum estradiol and sex
hormone binding globulin (SHBG) levels, increased
Table 1
Continuous predictors of breast cancer among premenopausal women in Nigeria, 1998–2000
95%
Predictor Cases Controls Odds ratio confidence interval P value
Age (years) 38.34 (6.55) 34.23 (8.80) 1.07 1.04–1.10 <0.01
Total number of pregnancies 4.41 (2.29) 3.82 (2.69) 0.90 0.79–1.03 0.13
Age at menarche (years) 15.01 (1.88) 15.51 (2.30) 0.86 0.77–0.97 0.01
Age at first full-term pregnancy (years) 23.80 (4.30) 22.54 (3.70) 1.09 1.02–1.16 0.01
Height (cm) 160.50 (8.62) 159.38 (7.17) 1.03 1.00–1.07 0.07
Weight (kg) 64.25 (14.51) 65.52 (15.28) 1.01 0.99–1.03 0.19
Body mass index (weight/height2) 24.76 (5.55) 23.65 (4.85) 1.02 0.97–1.07 0.54
Waist circumference (cm) 80.60 (11.84) 77.56 (10.73) 1.01 0.99–1.04 0.28
Hip circumference (cm) 99.03 (14.89) 97.07 (11.07) 1.01 0.99–1.02 0.61
Data presented as mean (standard deviation), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.peripheral fat conversion of estrogens to progesterone
and increased serum testosterone levels that may be
associated with an increased risk of breast cancer [17].
Estrogens are necessary for normal breast development,
and they induce and promote mammary tumor growth in
animal studies [18]. In addition, the close association
between increased risk of breast cancer and certain repro-
ductive factors such as early menarche and late
menopause [19], as well as the fall off in the rate of
increase in the incidence of disease at menopause [20]
and the lowered risk of breast cancer in oophorectomized
women and those taking antiestrogens [21,22], all
support the role of estrogen in breast carcinogenesis.
The results from cohort studies about the association
between WHR and the risk of breast cancer are inconsis-
tent. In the Nurses’ Health Study, the adjusted risk for the
highest quintile compared with the lowest quintile of WHR
among postmenopausal women who had never used
hormone replacement therapy was 1.85 (95% confidence
interval=1.25–2.74) [23]. Kaaks et al. reported a risk ratio
of 2.63 (95% confidence interval=1.09–6.35) comparing
the highest quintile with the lowest quintile of WHR [24].
These are similar to the results obtained in the present
study. In contrast, the Iowa Women’s Health Study
showed no association with WHR, and an earlier report of
interaction with family history appeared to have attenuated




Categorical predictors of breast cancer among premenopausal women in Nigeria, 1998–2000
95%
Predictor Cases Controls Odds ratio confidence interval P value
Waist–hip ratio
≤0.77 37 (30.8) 64 (35.6) 1.00
>0.77to≤0.85 45 (37.5) 78 (43.3) 0.88 0.50–1.55 0.65
>0.85 38 (31.67) 38 (21.2) 1.41 0.80–2.78 0.22
Family history of breast cancer
Yes 11 (9.17) 14 (7.78) 1.37 0.58–3.22 0.48
No 109 (90.83) 166 (92.22)
Obesity (body mass index ≥30)
Yes 29 (24.17) 25 (13.89) 1.52 0.82–2.82 0.18
No 91 (75.83) 155 (86.11)
Having ever breastfed
Yes 102 (85.71) 133 (73.89) 1.04 0.50–2.18 0.91
No 17 (14.29) 47 (26.11)
Use of contraceptive pill
Yes 53 (45.30) 62 (34.44) 0.84 0.51–1.39 0.50
No 64 (54.70) 118 (65.56)
Social status
Low 54 (46.15) 98 (54. 75) 1.00 0.15
Middle 60 (51.28) 80 (44.69) 1.36 0.85–2.18
High 3 (2.56) 1 (0.56) 5.44 0.55–53.62
Data presented as number (%), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.
Table 3
Multivariable odds ratio, 95% confidence interval and P value,
adjusted for age in categories, age at first pregnancy, height
and age at menarche in premenopausal women in Nigeria,
1998–2000
Adjusted 95%
Predictor odds ratio confidence interval P value
Waist–hip ratio
≤0.77 1.00
>0.77to≤0.85 0.80 0.40–1.60 0.53
>0.85 1.80 0.85–3.81 0.13Breast Cancer Research    Vol 5 No 2 Adebamowo et al.
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Table 4
Continuous predictors of breast cancer among postmenopausal women in Nigeria, 1998–2000
95%
Predictor Cases Controls Odds ratio confidence interval P value
Age (years) 53.62 (9.55) 58.42 (7.92) 0.939 0.09–0.97 0.01
Total number of pregnancies 5.99 (2.21) 6.75 (2.24) 0.89 0.71–1.02 0.10
Age at menarche (years) 15.58 (2.11) 16.35 (2.72) 0.89 0.78–1.02 0.08
Age at first full-term pregnancy (years) 23.34 (4.23) 22.99 (4.20) 0.98 0.92–1.06 0.65
Age at onset of natural menopause (years) 47.37 (6.49) 50.02 (5.59) 0.97 0.91–1.03 0.35
Height (cm) 159.37 (6.66) 155.99 (9.33) 1.07 1.02–1.13 0.01
Weight (kg) 65.52 (15.28) 62.32 (13.66) 1.02 1.00–1.04 0.07
Body mass index (weight/height2) 25.71 (5.86) 25.39 (5.63) 1.02 0.97–1.08 0.48
Waist (cm) 86.11 (14.18) 83.28 (10.36) 1.01 1.00–1.05 0.03
Hip (cm) 102.31 (17.05) 102.88 (16.93) 1.00 0.98–1.02 0.93
Data presented as mean (standard deviation), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.
Table 5
Comparison of categorical predictors of breast cancer among postmenopausal women in Nigeria, 1998–2000
95%
Predictor Cases Controls Odds ratio confidence interval P value
Waist–hip ratio
≤0.77 16 (15.4) 21 (23.6) 1.00
>0.77 to ≤ 0.85 40 (38.5) 40 (44.9) 1.52 0.67–3.42 0.31
>0.85 48 (46.15) 28 (31.5) 2.79 1.21–6.45 0.02
Family history of breast cancer
Yes 7 (6.73) 8 (8.99) 0.70 0.23–2.09 0.52
No 97 (93.27) 81 (91.01)
Obesity
Yes 31 (29.81) 16 (17.98) 2.01 0.99–4.09 0.05
No 73 (70.19) 73 (82.02)
Having ever breastfed
Yes 101 (97.12) 89 (100) aa a
No 3 (2.88) 0 (0)
Use of contraceptive pill
Yes 34 (34) 25 (28.09) 0.96 0.50–1.84 0.90
No 66 (66) 64 (71.91)
Social status
Low 49 (47.12) 57 (64.77) 1.00 0.97–3.19 0.06
Middle 47 (45.19) 31 (35.23) 1.79
High 8 (7.69) 0  aa
Data presented as number (%), age-adjusted odds ratio, 95% confidence interval, and P value for cases and controls.
a Values could not be computed because of zero-cell.Health Study, the multivariable analysis showed an associ-
ation between the lowest quintile and the highest quintile
of WHR and breast cancer of 1.72 (95% confidence inter-
val=1.0–3.1) among premenopausal women, but there
was no association among postmenopausal women [27].
Most case–control studies have found an association
between WHR and the risk of postmenopausal breast
cancer [28–37], and most report either null or weakly pos-
itive association with premenopausal breast cancer. In the
present study, there was no statistically significant associ-
ation between breast cancer and WHR for pre-
menopausal women.
Studies of WHR and the risk of breast cancer are limited
by systematic bias in the measurement of WHR across
studies [36], which may have been controlled somewhat
in this study by using nurse interviewers and adhering to
the World Health Organization MONICA guidelines [10].
In case–control studies like the present one, selection and
recall bias can be problematic. While we restricted our
analysis to urban dwellers, finer adjustment based on the
community of residence or the restriction of cases to only
those from the community from which controls were
selected would have increased the validity of the result.
The finding of two cases of cancer among the controls
may be due to chance.
The prevalence of obesity in the cases and controls also
appears higher than expected but this may be consistent
with the increasing rate of obesity in developing countries,
especially in the urban areas [38]. Preclinical weight loss
is not usually a problem in breast cancer [39], and sub-
analysis of our data confirmed this. Inclusion of obesity in
the multivariate analysis did not change the result, and
obesity was not a significant predictor of outcome in multi-
variate regression analysis. Other limitations of this study
include the absence of information about breastfeeding
and the features of a ‘Western lifestyle’ such as physical
activity, diet and use of postmenopausal hormones and
other medications.
In conclusion, the present study is consistent with findings
in other environments that central adiposity is a risk factor
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